BBNX vs BROS · rev $100.3M vs P/E 105, rev $1.02B
Beta Bionics, Inc. Common Stock (BBNX) versus Dutch Bros Inc (BROS) — a side-by-side from cached financials, not a winner call.
Beta Bionics, Inc. Common Stock (BBNX) is a medical devices company listed on NASDAQ.
Dutch Bros Inc (BROS) is a restaurants company listed on NYSE.
Latest reported BBNX revenue for 2025-12-31 was $100.3M. Net income was -$73.2M. Revenue was up 53.9% from 2024-12-31 to 2025-12-31. BBNX currently screens at market cap $640.8M.
Latest reported BROS revenue for 2026-06-30 was $1.02B. Net income was $53.5M. BROS currently screens at market cap $11.74B and trailing P/E 105.0.
BBNX currently screens at market cap $640.8M. BROS currently screens at market cap $11.74B and trailing P/E 105.0.
Not investment advice. Open the BBNX and BROS stock pages for the full models.
Not investment advice.